1. Home
  2. SION vs WASH Comparison

SION vs WASH Comparison

Compare SION & WASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • WASH
  • Stock Information
  • Founded
  • SION 2019
  • WASH 1800
  • Country
  • SION United States
  • WASH United States
  • Employees
  • SION N/A
  • WASH N/A
  • Industry
  • SION
  • WASH Major Banks
  • Sector
  • SION
  • WASH Finance
  • Exchange
  • SION NYSE
  • WASH Nasdaq
  • Market Cap
  • SION 564.4M
  • WASH 542.9M
  • IPO Year
  • SION 2025
  • WASH N/A
  • Fundamental
  • Price
  • SION $14.49
  • WASH $26.81
  • Analyst Decision
  • SION Strong Buy
  • WASH Buy
  • Analyst Count
  • SION 1
  • WASH 4
  • Target Price
  • SION $32.00
  • WASH $32.25
  • AVG Volume (30 Days)
  • SION 124.0K
  • WASH 121.1K
  • Earning Date
  • SION 05-12-2025
  • WASH 07-21-2025
  • Dividend Yield
  • SION N/A
  • WASH 8.34%
  • EPS Growth
  • SION N/A
  • WASH N/A
  • EPS
  • SION N/A
  • WASH N/A
  • Revenue
  • SION N/A
  • WASH $110,088,000.00
  • Revenue This Year
  • SION N/A
  • WASH $57.46
  • Revenue Next Year
  • SION N/A
  • WASH $9.82
  • P/E Ratio
  • SION N/A
  • WASH N/A
  • Revenue Growth
  • SION N/A
  • WASH N/A
  • 52 Week Low
  • SION $7.26
  • WASH $24.95
  • 52 Week High
  • SION $25.19
  • WASH $40.59
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • WASH 39.33
  • Support Level
  • SION N/A
  • WASH $26.69
  • Resistance Level
  • SION N/A
  • WASH $27.66
  • Average True Range (ATR)
  • SION 0.00
  • WASH 0.58
  • MACD
  • SION 0.00
  • WASH -0.09
  • Stochastic Oscillator
  • SION 0.00
  • WASH 6.90

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About WASH Washington Trust Bancorp Inc.

Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.

Share on Social Networks: